[A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
Year: 1990
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: T Shiraishi, Y Nio, S Imai, M Tsubono, H Morimoto, C C Tseng, T Tobe, T Tanaka, O Kitamura, S Sakanashi
Institution: Kyoto University
Language: Japanese
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4080690
